| Dr Thomas M Reardon, MD | |
|
2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116-3237 | |
| (816) 453-4000 | |
| (816) 842-1425 |
| Full Name | Dr Thomas M Reardon |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 2750 Clay Edwards Dr, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538168711 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | R1F96 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cameron Regional Medical Center | Cameron, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cameron Regional Medical Center Inc | 5092622001 | 58 |
News Archive
Cowboys lined the metal chutes that released bucking horses and their riders into the arena, Miss Rodeo Montana signed autographs for fans, and coronavirus warning signs ended with "Face mask usage is of personal choice."
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometer, in the atmosphere due to lockdown is associated with the arrival of a newer variant of SARS-CoV-2, which has eventually displaced the original virus after lockdown.
Health Canada is informing health care professionals and Canadians of recent changes to heparin manufacturing standards in the United States that will result in a decrease in the potency of certain heparin products by about 10 per cent.
› Verified 2 days ago
| Entity Name | Cameron Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811905375 PECOS PAC ID: 5092622001 Enrollment ID: O20040113000619 |
News Archive
Cowboys lined the metal chutes that released bucking horses and their riders into the arena, Miss Rodeo Montana signed autographs for fans, and coronavirus warning signs ended with "Face mask usage is of personal choice."
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometer, in the atmosphere due to lockdown is associated with the arrival of a newer variant of SARS-CoV-2, which has eventually displaced the original virus after lockdown.
Health Canada is informing health care professionals and Canadians of recent changes to heparin manufacturing standards in the United States that will result in a decrease in the potency of certain heparin products by about 10 per cent.
› Verified 2 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
Cowboys lined the metal chutes that released bucking horses and their riders into the arena, Miss Rodeo Montana signed autographs for fans, and coronavirus warning signs ended with "Face mask usage is of personal choice."
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometer, in the atmosphere due to lockdown is associated with the arrival of a newer variant of SARS-CoV-2, which has eventually displaced the original virus after lockdown.
Health Canada is informing health care professionals and Canadians of recent changes to heparin manufacturing standards in the United States that will result in a decrease in the potency of certain heparin products by about 10 per cent.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas M Reardon, MD 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116-3237 Ph: (816) 453-4000 | Dr Thomas M Reardon, MD 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116-3237 Ph: (816) 453-4000 |
News Archive
Cowboys lined the metal chutes that released bucking horses and their riders into the arena, Miss Rodeo Montana signed autographs for fans, and coronavirus warning signs ended with "Face mask usage is of personal choice."
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and provide a general corporate overview at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 10:30 a.m. EDT at the Grand Hyatt New York Hotel in New York City.
A recent study conducted at the University of Malta Medical School, Malta, has revealed that a drop in the level of particulate matter 2.5 (PM2.5), which are airborne pollutant particles with a diameter of 2.5 micrometer, in the atmosphere due to lockdown is associated with the arrival of a newer variant of SARS-CoV-2, which has eventually displaced the original virus after lockdown.
Health Canada is informing health care professionals and Canadians of recent changes to heparin manufacturing standards in the United States that will result in a decrease in the potency of certain heparin products by about 10 per cent.
› Verified 2 days ago
Dr. Kyle Harken, D.O. Surgery Medicare: May Accept Medicare Assignments Practice Location: 2750 Clay Edwards Dr Ste 600, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1486 | |
Dr. Jon S Gengler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1425 | |
Dr. Frank Scott Werner, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2750 Clay Edwards Dr, Suite 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1425 | |
Joshua Michael Mourot, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 600, North Kansas City, MO 64116 Phone: 816-691-5048 Fax: 816-346-7039 | |
Dr. Jun Ungos Elegino, DO Surgery Medicare: Medicare Enrolled Practice Location: 2750 Clay Edwards Dr Ste 312, North Kansas City, MO 64116 Phone: 816-453-4000 Fax: 816-842-1486 | |
Dr. Austin J Wagner, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 304, North Kansas City, MO 64116 Phone: 816-842-5555 Fax: 816-842-8888 | |
Dr. Scott W Kujath, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2750 Clay Edwards Dr, Suite 304, North Kansas City, MO 64116 Phone: 816-842-5555 Fax: 816-842-8888 |